Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 8;7(6):142.
doi: 10.3390/jcm7060142.

A Neglected Issue in Ulcerative Colitis: Mesenteric Lymph Nodes

Abdurrahman Sahin  1 , Hakan Artas  2 , Yesim Eroglu  3 , Nurettin Tunc  4 , Gulcan Oguz  5 , Ulvi Demirel  6 , Orhan Kursat Poyrazoglu  7 , Mehmet Yalniz  8 , Ibrahim Halil Bahcecioglu  9
Affiliations

A Neglected Issue in Ulcerative Colitis: Mesenteric Lymph Nodes

Abdurrahman Sahin et al. J Clin Med. .

Abstract

Data evaluating the presence and characteristics of mesenteric lymph nodes (LNs) in patients with ulcerative colitis (UC) are scarce. The aim of this study is to determine the presence and characteristics of LNs in UC. The LN characteristics in computed tomography (CT), including LN dimension and attenuation, were evaluated retrospectively in 100 patients with UC (61 active and 39 inactive cases). Clinical characteristics and laboratory parameters, including CBC, biochemical analysis, erythrocyte sedimentation rate (ESR), and C reactive protein (CRP) were also compared. Mesenteric LNs were evident in all patients with UC. The attenuation and dimension of mesenteric LNs did not differ between active and inactive patients with UC. No correlation was found among patients with UC in terms of LN dimension, attenuation, ESR, CRP, leucocyte, and albumin (all with p > 0.05). The current study suggested that inflammation results in the development of mesenteric LN in UC, similar to Crohn’s disease and other inflammatory disorders.

Keywords: attenuation; dimension; mesenteric lymph node; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Baumgart D.C., Carding S.R. Inflammatory bowel disease: Cause and immunobiology. Lancet. 2007;369:1627–1640. doi: 10.1016/S0140-6736(07)60750-8. - DOI - PubMed
    1. Kaser A., Zeissig S., Blumberg R.S. Inflammatory bowel disease. Annu. Rev. Immunol. 2010;28:573–621. doi: 10.1146/annurev-immunol-030409-101225. - DOI - PMC - PubMed
    1. Ordas I., Eckmann L., Talamini M., Baumgart D.C., Sandborn W.J. Ulcerative colitis. Lancet. 2012;380:1606–1619. doi: 10.1016/S0140-6736(12)60150-0. - DOI - PubMed
    1. Von der Weid P.Y., Rainey K.J. Review article: Lymphatic system and associated adipose tissue in the development of inflammatory bowel disease. Aliment. Pharmacol. Ther. 2010;32:697–711. doi: 10.1111/j.1365-2036.2010.04407.x. - DOI - PubMed
    1. Alexander J.S., Chaitanya G.V., Grisham M.B., Boktor M. Emerging roles of lymphatics in inflammatory bowel disease. Ann. N. Y. Acad. Sci. 2010;1207(Suppl. 1):E75–E85. doi: 10.1111/j.1749-6632.2010.05757.x. - DOI - PubMed

LinkOut - more resources